Thursday, 27 January 2022

Australia's most trusted
source of pharma news

Thursday, 27 January 2022

Gilead snags top Janssen exec

Posted 8 December 2021 AM

After working at Janssen for over a decade, most recently as Marketing Director for Immunology, Stephen Gray has joined Gilead Sciences - a company he has "admired" for over 20 years.

Starting his new role as Senior Business Unit Director (HIV) this week, Gray posted on LinkedIn: "Today I feel both privileged and excited to start a new chapter in my career, joining Gilead, an organisation I've admired for 20+ years for their scientific ingenuity particularly in infectious diseases.

To see the whole article, please login

Email this article to a friend

Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.


Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.


Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).


You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.


You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.